First Manhattan
CERE

First Manhattan’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

First Manhattan’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$4.23K – 1396
2024
Q1 		$4.23K Hold
100
– – ﹤0.01% 1213
2023
Q4 		$4.24K Hold
100
– – ﹤0.01% 1215
2023
Q3 		$2.18K Buy
+100
New +$2.18K ﹤0.01% 1307